Bruker (BRKR) Non-Current Deferred Tax Liability (2010 - 2025)
Bruker (BRKR) posted Non-Current Deferred Tax Liability of $112.5 million for Q4 2025, down 5.06% on a QoQ basis from $118.5 million in Q4 2024, and down 5.06% year-over-year from $118.5 million in Q4 2024.
Bruker (BRKR) Non-Current Deferred Tax Liability (2010 - 2025) Analysis & Trends
Bruker's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $112.5 million for Q4 2025.
- Quarterly Non-Current Deferred Tax Liability fell 5.06% year-over-year to $112.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $112.5 million (down 5.06% YoY) and the FY2025 annual result came in at $112.5 million, down 5.06% from the prior year.
- Non-Current Deferred Tax Liability was $112.5 million for Q4 2025 at Bruker, down from $118.5 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $178.5 million in Q2 2024 and bottomed at $46.0 million in Q4 2021.
- A 5-year average of $105.7 million and a median of $97.1 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 75.04% — and 2025, when it fell 5.06%.
- Bruker's Non-Current Deferred Tax Liability stood at $46.0 million in 2021, then jumped by 35.43% to $62.3 million in 2022, then rose by 8.67% to $67.7 million in 2023, then soared by 75.04% to $118.5 million in 2024, then declined by 5.06% to $112.5 million in 2025.
- Business Quant data shows BRKR's Non-Current Deferred Tax Liability at $112.5 million in Q4 2025, $118.5 million in Q4 2024, and $178.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112.50 Mn |
| Dec 31, 2025 | 112.50 Mn |
| Dec 31, 2024 | 118.50 Mn |
| Dec 31, 2024 | 118.50 Mn |
| Sep 30, 2024 | 178.40 Mn |
| Sep 30, 2024 | 178.40 Mn |
| Jun 30, 2024 | 178.50 Mn |
| Jun 30, 2024 | 178.50 Mn |
| Mar 31, 2024 | 81.80 Mn |
| Mar 31, 2024 | 81.80 Mn |
| Dec 31, 2023 | 67.70 Mn |
| Dec 31, 2023 | 67.70 Mn |
| Dec 31, 2022 | 62.30 Mn |
| Dec 31, 2022 | 62.30 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Dec 31, 2020 | 43.10 Mn |
| Dec 31, 2020 | 43.10 Mn |
| Dec 31, 2019 | 48.80 Mn |
| Dec 31, 2019 | 48.80 Mn |